What is the current market valuation of the US retinal vein-occlusion market?

The market valuation was $410.82 Million in 2024. Read More

What is the projected market size for the US retinal vein-occlusion market by 2035?

The market is projected to reach $800.0 Million by 2035. Read More

What is the expected CAGR for the US retinal vein-occlusion market during the forecast period 2025 - 2035?

The expected CAGR is 6.25% during the forecast period 2025 - 2035. Read More

Which treatment approaches dominate the US retinal vein-occlusion market?

Intravitreal injections are expected to lead with a valuation of $200.0 - $400.0 Million. Read More

What are the key segments in the US retinal vein-occlusion market?

Key segments include Branch Retinal Vein Occlusion, Central Retinal Vein Occlusion, and Hemiretinal Vein Occlusion. Read More

How do hospitals compare to ophthalmology clinics in terms of market share?

Hospitals are valued at $150.0 - $300.0 Million, while ophthalmology clinics are valued at $180.82 - $360.0 Million. Read More

What distribution channels are utilized in the US retinal vein-occlusion market?

Distribution channels include direct sales, retail pharmacies, and online pharmacies. Read More

Which companies are considered key players in the US retinal vein-occlusion market?

Key players include Regeneron Pharmaceuticals, Novartis, Bayer, and Roche. Read More

What is the valuation range for Central Retinal Vein Occlusion in the market?

The valuation range for Central Retinal Vein Occlusion is $205.41 - $400.0 Million. Read More

What is the expected growth trend for the US retinal vein-occlusion market?

The market is likely to experience steady growth, reaching $800.0 Million by 2035. Read More

US Retinal Vein Occlusion Market

ID: MRFR/Pharma/11747-HCR

100 Pages

Satyendra Maurya

Last Updated: April 06, 2026

US Retinal Vein Occlusion Market Research Report: By Type (Branch Retinal Vein Occlusion, Central Retinal Vein Occlusion, Hemiretinal Vein Occlusion), By Treatment Approach (Laser Therapy, Intravitreal Injections, Surgery), By End User (Hospitals, Ophthalmology Clinics, Ambulatory Surgical Centers) and By Distribution Channel (Direct Sales, Retail Pharmacies, Online Pharmacies) - Growth & Industry Forecast 2025 To 2035

US Retinal Vein Occlusion Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Medical Device, BY Type (USD Million)
  1. 4.1.1 Branch Retinal Vein Occlusion
  2. 4.1.2 Central Retinal Vein Occlusion
  3. 4.1.3 Hemiretinal Vein Occlusion
2. 4.2 Medical Device, BY Treatment Approach (USD Million)
  1. 4.2.1 Laser Therapy
  2. 4.2.2 Intravitreal Injections
  3. 4.2.3 Surgery
3. 4.3 Medical Device, BY End User (USD Million)
  1. 4.3.1 Hospitals
  2. 4.3.2 Ophthalmology Clinics
  3. 4.3.3 Ambulatory Surgical Centers
4. 4.4 Medical Device, BY Distribution Channel (USD Million)
  1. 4.4.1 Direct Sales
  2. 4.4.2 Retail Pharmacies
  3. 4.4.3 Online Pharmacies
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Medical Device
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Regeneron Pharmaceuticals (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Novartis (CH)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Bayer (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Roche (CH)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Allergan (IE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Santen Pharmaceutical (JP)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Apellis Pharmaceuticals (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Horizon Therapeutics (IE)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TYPE
3. 6.3 US MARKET ANALYSIS BY TREATMENT APPROACH
4. 6.4 US MARKET ANALYSIS BY END USER
5. 6.5 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
6. 6.6 KEY BUYING CRITERIA OF MEDICAL DEVICE
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF MEDICAL DEVICE
9. 6.9 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
10. 6.10 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
11. 6.11 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
12. 6.12 MEDICAL DEVICE, BY TYPE, 2024 (% SHARE)
13. 6.13 MEDICAL DEVICE, BY TYPE, 2024 TO 2035 (USD Million)
14. 6.14 MEDICAL DEVICE, BY TREATMENT APPROACH, 2024 (% SHARE)
15. 6.15 MEDICAL DEVICE, BY TREATMENT APPROACH, 2024 TO 2035 (USD Million)
16. 6.16 MEDICAL DEVICE, BY END USER, 2024 (% SHARE)
17. 6.17 MEDICAL DEVICE, BY END USER, 2024 TO 2035 (USD Million)
18. 6.18 MEDICAL DEVICE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
19. 6.19 MEDICAL DEVICE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY TREATMENT APPROACH, 2025-2035 (USD Million)
  3. 7.2.3 BY END USER, 2025-2035 (USD Million)
  4. 7.2.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Medical Device Market Segmentation

Medical Device By Type (USD Million, 2025-2035)

Branch Retinal Vein Occlusion
Central Retinal Vein Occlusion
Hemiretinal Vein Occlusion

Medical Device By Treatment Approach (USD Million, 2025-2035)

Laser Therapy
Intravitreal Injections
Surgery

Medical Device By End User (USD Million, 2025-2035)

Hospitals
Ophthalmology Clinics
Ambulatory Surgical Centers

Medical Device By Distribution Channel (USD Million, 2025-2035)

Direct Sales
Retail Pharmacies
Online Pharmacies

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”